Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound preparation used for treating melancholia and senile dementia

A compound preparation, senile technology, applied in the field of compound preparations for the treatment of depression and senile dementia, to achieve the effect of solving vomiting

Active Publication Date: 2010-10-06
兰晟生物医药(苏州)有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The technical problem to be solved by this invention is to provide a compound preparation for the treatment of depression and senile dementia for the above-mentioned current state of the art, which has an effective therapeutic effect on depression and senile dementia, and solves the problems of the prior art at the same time. Technical problems of rolipram causing adverse reactions such as vomiting, nausea, and headache

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound preparation used for treating melancholia and senile dementia
  • Compound preparation used for treating melancholia and senile dementia
  • Compound preparation used for treating melancholia and senile dementia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The compound preparation for treating depression and senile dementia of this embodiment includes 1 part of rolipram and 0.25 part of granisetron in parts by weight.

Embodiment 2

[0036] The compound preparation for treating depression and senile dementia of this embodiment includes 1 part of rolipram and 2 parts of granisetron in parts by weight.

Embodiment 3

[0038] The compound preparation for treating depression and senile dementia of this embodiment includes 1 part of rolipram and preferably 1 part of granisetron in parts by weight.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a compound preparation used for treating depression and senile dementia. The compound preparation comprises the following components in part by weight: 1 part of rolipram and 0.25 to 200 parts of antiemetic medicament, wherein the antiemetic medicament is granisetron, ondansetron, tropisetron, aprepitant or metoclopramide. The compound preparation is prepared from the rolipram and the granisetron, the ondansetron, the tropisetron, the aprepitant or the metoclopramide. The compound preparation has an effective curative effect of treating the melancholia and the senile dementia, and simultaneously solves the technical problems that in the prior art, the rolipram causes adverse reactions such as vomition, sicchasia, headache and the like.

Description

technical field [0001] The invention relates to a medicament, specifically a compound preparation for treating depression and senile dementia. Background technique [0002] In the past two decades, with the deepening of understanding of rolipram and phosphodiesterase 4 (PDE4), PDE4 inhibitors are not only limited to the potential of central nervous system diseases, but also have anti-inflammatory effects such as asthma, COPD ( Chronic obstructive pulmonary disease), rheumatoid arthritis and other inflammatory disease animal models also have good results. Therefore, it is particularly important to develop new PDE4 inhibitors and reduce the adverse reactions of such inhibitors. Rolipram, a classic inhibitor of phosphodiesterase 4 (PDE4), was once marketed as an antidepressant drug, comparable to the classic tricyclic antidepressant drug amitriptyline, but it was blocked due to adverse reactions such as vomiting, nausea, and headache. Clinical application. The specific mecha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/4015A61K31/4178A61K31/439A61K31/46A61K31/5355A61P25/24A61P25/28A61K31/166
Inventor 徐江平
Owner 兰晟生物医药(苏州)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com